To reforming economics as an interpretation of reality, rather than a diversion play for monopolists.
Big Pharma's Covid Exposure
Has Big Pharma exposed society to undue risk in the covid era? In our 2nd episode on this issue, Tahir Amin (i-mak.org) takes us through the R & D ecosystem of pharmaceutical development. Is Big Pharma's role to develop life saving products or digest competition? Listeners will understand why this market is in urgent need of a major overhaul. As always, policy pathways are provided as a matter of courtesy. Show notes
The Planning Blame Game Diversion
A recording from Prof Nicole Gurran’s 129th Annual Henry George Commemorative Dinner: "So in terms of affordable rental housing, if granny flats are it, we were going great guns." Prof Gurran takes us through the motivations of blaming planning for affordability issues versus how well the sector actually performs. Transcript & Vid.
The Miracle of the Rentenmark
With the corona crash only just beginning economically speaking, we need the best tools available. So we delve back into the archives to this 2012 interview with the late Dr Adrian Wrigley. Dr Wrigley looks at how the link between currency creation and land rents is key to a stable economy where reward is based on effort, not privilege. There are some important learnings here as more jurisdictions look at local currencies as a recovery tool. Transcription & show notes.
Reform Theatre and the Global Housing Crisis
Will McMahon (Action on Empty Homes, UK) and Helene Caloir (Local Initiatives Support Corporation, NY) join host Karl Fitzgerald to discuss the global housing crisis in light of one of our regular themes - vacancy. A global issue calls for a global response yes? We discuss pandemic related themes to empty homes, homelessness and the international nature of commodification. Can we work together to move beyond the reform theatre enveloping housing policy? A big announcement looms. Show notes.
Big Pharma Plays the Pandemic
Renowned health economist Stephen Duckett (Grattan Institute) discusses our health system’s ability to address the pandemic. From preventative practices to problems with our private health system, we then delve into issues surrounding medical R&D. Have the oligopolistic practices of Big Pharma exposed society to undue risk in this cover era? Some hard questions need to be asked! Show notes
Monopoly Interests in the Pandemic
Based on a recent event we held Airlines, Highways and Airwaves, Policy Director Jesse Hermans joins to discuss the power of monopoly in the pandemic era. We discuss why monopolists should also be sharing in the pain of the pandemic and why governments could be ensuring this occurs before bailouts are requested. Show notes.